Heart Disease Clinical Trials in Houston

Showing 21-40 of 186 trials

Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction

NCT05839730

FIRE-HFpEF is a multi-center, prospective, randomized, single-blinded, clinical feasibility study. This study will enroll up to 105 subjects with heart failure with preserved ejection fraction in the United States. Data will be collected to evaluate whether pacing therapies can lead to improvements in exercise capacity and health status of subjects.

Heart Failure With Preserved Ejection FractionConcentric Hypertrophy

Medtronic Cardiac Rhythm and Heart Failure105 participantsStarted Sep 2024

Naples, Florida, United States • O'Fallon, Illinois, United States • Springfield, Illinois, United States +6 more locations

RECRUITINGNA< 1 mile

Assessment of CCM in HF With Higher Ejection Fraction

NCT05064709

The AIM HIGHer Clinical Trial will evaluate the safety and efficacy of Cardiac Contractility Modulation (CCM) therapy in patients with heart failure with LVEF ≥40% and ≤70%.

Heart FailureHeart Failure With Preserved Ejection FractionHeart Failure With Mid Range Ejection Fraction+2 more

Impulse Dynamics1,500 participantsStarted Feb 2022

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Mesa, Arizona, United States +109 more locations

Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction

Assessment of CCM in HF With Higher Ejection Fraction

Heart Disease Trials in Other Cities

Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)

STeroids to REduce Systemic Inflammation After Infant Heart Surgery

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)

SyncAV Post-Market Trial

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes

Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE)

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR

ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation

Personalized Therapy Study - HFRS (TriageHF) Post Approval Study

EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction

SELUTION 4 De Novo Small Vessel IDE Trial

Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure

Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease

An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure

Diagnosis and Treatment of CAD in Severe PAD After Lower Extremity Revascularization

Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease

Other Conditions in Houston